Transcutaneous Auricular Vagus Nerve Stimulation in Pediatric Patients: A Systematic Review of Clinical Treatment Protocols and Stimulation Parameters

被引:6
|
作者
Sigrist, Christine [1 ,2 ]
Torki, Bushra [1 ,2 ]
Bolz, Lars -Oliver [3 ]
Jeglorz, Tobias [4 ]
Bolz, Armin [1 ,3 ]
Koenig, Julian [1 ,2 ]
机构
[1] Univ Cologne, Fac Med, Dept Child & Adolescent Psychiat Psychosomat & Psy, Robert Koch Str 10,Bldg 53,Room 1-009, D-50931 Cologne, Germany
[2] Univ Cologne, Univ Hosp Cologne, Robert Koch Str 10,Bldg 53,Room 1-009, D-50931 Cologne, Germany
[3] tVNS Technol GmbH, Erlangen, Germany
[4] Sasse Elekt GmbH, Schwabach, Germany
来源
NEUROMODULATION | 2023年 / 26卷 / 03期
关键词
Children and adolescents; neurodevelopment; pediatrics; transcutaneous vagus nerve stimulation; EPILEPSY; EFFICACY; THERAPY; SPAN;
D O I
10.1016/j.neurom.2022.07.007
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Noninvasive transcutaneous vagus nerve stimulation (tVNS) has promising therapeutic potential in a wide range of applications across somatic and psychiatric conditions. Compared with invasive vagus nerve stimulation, good safety and tolerability profiles also support the use of tVNS in pediatric patients. Potential neurodevelopment-specific needs, however, raise concerns regarding the age-appropriate adjustment of treatment protocols and applied stimulation parameters.Objective: In this study, we aimed to review registered trials and published studies to synthesize existing tVNS treatment protocols and stimulation parameters applied in pediatric patients.Materials and Methods: A systematic search of electronic data bases (PubMed, Scopus, MEDLINE, Cochrane Library, and Psy-cINFO) and ClinicalTrials was conducted. Information on patient and study-level characteristics (eg, clinical condition, sample size), the tVNS device (eg, brand name, manufacturer), stimulation settings (eg, pulse width, stimulation intensity), and stimu-lation protocol (eg, duration, dosage of stimulation) was extracted.Results: We identified a total of 15 publications (four study protocols) and 15 registered trials applying tVNS in pediatric patients (<18 years of age). Most of these studies did not exclusively address pediatric patients. None of the studies elaborated on neurodevelopmental aspects or justified the applied protocol or stimulation parameters for use in pediatric patients.Conclusions: No dedicated pediatric tVNS devices exist. Neither stimulation parameters nor stimulation protocols for tVNS are properly justified in pediatric patients. Evidence on age-dependent stimulation effects of tVNS under a neurodevelopment framework is warranted. We discuss the potential implications of these findings with clinical relevance, address some of the challenges of tVNS research in pediatric populations, and point out key aspects in future device development and research in addition to clinical studies on pediatric populations.
引用
收藏
页码:507 / 517
页数:11
相关论文
共 50 条
  • [41] Transcutaneous auricular vagus nerve stimulation for pediatric epilepsy: study protocol for a randomized controlled trial
    He, Wei
    Wang, Xiao-Yu
    Zhou, Li
    Li, Zhi-Mei
    Jing, Xiang-Hong
    Lv, Zhong-Li
    Zhao, Yu-Feng
    Shi, Hong
    Hu, Ling
    Su, Yang-Shuai
    Zhu, Bing
    TRIALS, 2015, 16
  • [42] Effect of transcutaneous auricular vagus nerve stimulation on delayed neurocognitive recovery in elderly patients
    Qi Zhou
    Lili Yu
    Chunping Yin
    Qi Zhang
    Xupeng Wang
    Kai Kang
    Decheng Shao
    Qiujun Wang
    Aging Clinical and Experimental Research, 2022, 34 : 2421 - 2429
  • [43] Transcutaneous vagus nerve stimulation
    Stefan, H.
    ZEITSCHRIFT FUR EPILEPTOLOGIE, 2014, 27 (01): : 26 - 30
  • [44] Transcutaneous Auricular Vagus Nerve Stimulation Facilitates Cortical Arousal and Alertness
    Chen, Yuxin
    Lu, Xuejing
    Hu, Li
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2023, 20 (02)
  • [45] Transcutaneous auricular vagus nerve stimulation augments postprandial inhibition of ghrelin
    Kozorosky, Erica M.
    Lee, Cristina H.
    Lee, Jessica G.
    Martinez, Valeria Nunez
    Padayachee, Leandra E.
    Stauss, Harald M.
    PHYSIOLOGICAL REPORTS, 2022, 10 (08):
  • [46] Effect of transcutaneous auricular vagus nerve stimulation on delayed neurocognitive recovery in elderly patients
    Zhou, Qi
    Yu, Lili
    Yin, Chunping
    Zhang, Qi
    Wang, Xupeng
    Kang, Kai
    Shao, Decheng
    Wang, Qiujun
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (10) : 2421 - 2429
  • [47] Transcutaneous auricular vagus nerve stimulation (taVNS) for migraine: an fMRI study
    Zhang, Yue
    Huang, Yiting
    Li, Hui
    Yan, Zhaoxian
    Zhang, Ying
    Liu, Xian
    Hou, Xiaoyan
    Chen, Weicui
    Tu, Yiheng
    Hodges, Sierra
    Chen, Helen
    Liu, Bo
    Kong, Jian
    REGIONAL ANESTHESIA AND PAIN MEDICINE, 2021, 46 (02) : 145 - 150
  • [48] Transcutaneous auricular vagus nerve stimulation alters cough sensitivity depending on stimulation parameters: potential implications for aspiration risk
    Ng, Karen B.
    Hernandez, Esther Guiu
    Haszard, Jillian
    Macrae, Phoebe
    Huckabee, Maggie-Lee
    Cakmak, Yusuf O.
    FRONTIERS IN NEUROSCIENCE, 2024, 18
  • [49] Direct and Transcutaneous Vagus Nerve Stimulation for Treatment of Tinnitus: A Scoping Review
    Yakunina, Natalia
    Nam, Eui-Cheol
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [50] Tinnitus treatment by vagus nerve stimulation: A systematic review
    Stegeman, I
    Velde, H. M.
    Robe, P. A. J. T.
    Stokroos, R. J.
    Smit, A. L.
    PLOS ONE, 2021, 16 (03):